Testosterone for Women: Benefits, Risks, and What to Expect
Testosterone is a normal part of female physiology, produced by the ovaries and adrenal glands throughout a woman's life. No FDA-approved testosterone product exists for women in the United States, so prescribing is off-label. Evidence is strongest for improving sexual desire in postmenopausal women; other reported benefits require individualized evaluation. Side effects are real and some are not readily reversible. Provider oversight and lab monitoring matter.
You've probably been told testosterone is a male hormone. Maybe your labs came back "normal" and your provider moved on, even though you still feel like something is off. Fatigue that sleep doesn't fix, a libido that's quietly disappeared, a body that stopped responding to the training and habits that used to work. You weren't imagining it. The dismissal, though, that part was a problem.
Testosterone is not a male hormone. It is a hormone that men produce in significantly higher quantities, which is a different statement entirely. Women produce it throughout their lives, it performs specific and well-understood functions in the female body, and levels decline with age in ways that are clinically relevant. The conversation about hormone therapy for women has historically focused almost entirely on estrogen and progesterone, leaving testosterone out of the picture in a way that has not served women particularly well.
This post covers what testosterone actually does in the female body, what low levels look like, what the evidence does and does not support, how assessment and delivery work, what the risks are, and the regulatory context you deserve to understand before making any decisions. Nothing here is meant to diagnose or substitute for a clinical evaluation.
What does testosterone actually do in the female body?
Testosterone is produced primarily by the ovaries and, to a lesser extent, the adrenal glands. It circulates at much lower concentrations in women than in men, but it is present across a woman's entire lifespan and serves specific physiological functions that are not replicated by estrogen or progesterone.
In the female body, testosterone contributes to sexual desire and arousal, the maintenance of lean muscle mass and bone density, energy regulation, and cognitive function including focus and mental clarity. It also plays a role in mood stability. These are not edge effects. They are documented functions tied to androgen receptors present throughout the body, including in the brain, muscle tissue, and bone.
Testosterone production in women does decline with age, and the decline accelerates around perimenopause. Women who have had their ovaries removed surgically experience a more abrupt drop. This is not supplementation with a foreign substance. It is the replacement of something the body made in meaningful quantities and no longer does.
What does low testosterone look like in women?
The symptoms associated with low testosterone in women overlap substantially with other conditions, which is part of why it gets overlooked. Persistent fatigue that is not explained by poor sleep or thyroid dysfunction, reduced or absent libido, loss of muscle tone despite consistent training, difficulty maintaining body composition, low mood, reduced motivation, and mental fog are the most commonly reported symptoms.
The overlap with perimenopause, thyroid dysfunction, iron deficiency anemia, sleep disorders, and depression is real and clinically significant. That is exactly why a symptom list alone is not sufficient for diagnosis. A hormone imbalance evaluation should include lab work and a differential process that rules out other contributors before attributing symptoms to testosterone deficiency. If mood symptoms are the primary concern, our guide on perimenopause and depression is worth reading alongside this one.
What are the potential benefits of testosterone therapy for women?
This section warrants precision, because the evidence base is not uniform across all the claimed benefits.
The strongest evidence supports improvement in sexual desire and satisfaction in postmenopausal women. Multiple systematic reviews have found that testosterone therapy may improve sexual wellness outcomes including desire, arousal, and frequency in this population. That evidence is meaningful and should not be minimized. The UK's National Institute for Health and Care Excellence recommends testosterone supplementation for menopausal women with low sexual desire when standard hormone therapy alone has not been effective.
For other commonly cited benefits, the evidence is thinner or more variable. Some patients report improved energy, better mood, and greater mental clarity during testosterone therapy. These effects have been observed in clinical settings and reported consistently in patient experience, but the research base is less conclusive than it is for sexual function. Testosterone has also been associated with support for lean muscle mass and bone density, both of which are relevant for women in midlife and beyond.
What is not supported by evidence is a universal or guaranteed outcome. Individual response varies, and the degree of benefit depends on the severity of the underlying deficiency, the delivery method, the patient's overall hormonal picture, and other factors. Every benefit statement here reflects what may occur with appropriate therapy in appropriate candidates, not what will occur in every case.
How are testosterone levels assessed in women?
Assessment typically includes total testosterone and free testosterone, along with sex hormone binding globulin (SHBG). SHBG binds to testosterone in the bloodstream, which means total testosterone alone does not tell the full clinical story. Free testosterone, the portion not bound to SHBG and biologically active, is often the more clinically relevant number.
A single lab value out of context is not a diagnosis. This is worth stating plainly, because many women arrive having been told their testosterone is "within normal range" without any discussion of how they feel, whether their free levels were checked, or where in their cycle the blood was drawn. Lab results are one input. Symptoms, health history, other hormone levels, and a clinical assessment of what else might be contributing all factor into the decision about whether therapy is appropriate.
Specific reference ranges and target numbers are not published here because they vary by laboratory, methodology, and individual clinical context. Publishing them without that context creates more confusion than clarity.
What are the delivery methods for testosterone in women?
Three primary delivery methods are used in clinical practice: subcutaneous pellets, injections, and topical creams. Each has a distinct profile in terms of how consistently hormone levels are maintained, how frequently the patient interacts with the treatment, and how easily the dose can be adjusted.
| Method | Level stability | Adjustability | Patient involvement | Main consideration |
|---|---|---|---|---|
| Pellets | Most consistent. Releases gradually over several months | Lowest. Cannot be modified once placed; changes happen at next insertion | Lowest. Two to four in-office insertions per year | Conservative initial dosing matters because the dose cannot be walked back |
| Injections | Peaks and troughs between doses, more pronounced than pellets | Highest. Dose can change at the next administration | Scheduled weekly or every two weeks | Useful when levels need dialing in or response is variable |
| Topical cream | Variable. Depends on absorption, skin condition, and application site | High. Adjusted between refills | Highest. Daily application, adherence required | Documented risk of transfer to partners or children through skin contact |
Specific dosing is determined by your provider based on labs, symptoms, and response. This comparison covers how each method behaves, not how much is prescribed.
The right delivery method depends on how a patient's body responds, her lifestyle, how important dose flexibility is, and her preference for frequency of interaction with the treatment. These are clinical decisions made in the context of a full evaluation, not a preference survey. You can read more about hormone pellet therapy for men and women in Las Vegas.
Mia LoPreiato, NP and Teresa Hernandez, MSN FNP-BC at a Biote certification event. Both providers are Biote-Certified.
Biote certification means completed training in the Biote Method of hormone pellet therapy, including structured protocols for dosing, insertion technique, and follow-up laboratory monitoring.
What are the side effects and risks of testosterone therapy in women?
Side effects are real, and some of them are not readily reversible. This section is not a disclaimer. It is clinically relevant information that should factor into your decision.
The most commonly reported side effects include acne and increased skin oiliness, unwanted hair growth on the face or body, and scalp hair thinning. These are generally dose-related, meaning they are more likely at higher concentrations and may improve with dose adjustment. Mood changes including irritability have also been reported, though some patients describe the opposite effect. Fluid retention can occur as well.
The distinction that matters most is which effects resolve and which may not.
Typically improve with dose adjustment
- Acne and increased skin oiliness
- Unwanted hair growth on the face or body
- Mood changes, including irritability
- Fluid retention and mild bloating
- Scalp hair thinning, in many cases
- Changes in lipid markers
May not fully reverse
- Voice deepening
- Clitoral enlargement beyond a mild degree
- Scalp hair loss in genetically susceptible women, in some cases
These are more commonly associated with levels above the female physiologic range. Report voice changes or rapid onset of androgenic effects before your next scheduled visit rather than waiting.
Monitoring exists specifically to catch the right-hand column early, while it is still the left-hand column.
Follow-up labs, symptom check-ins, and dose adjustments over time are not bureaucratic formalities. They are the mechanism by which side effects are caught and addressed before they become irreversible. This is one of the strongest arguments for supervised, in-person hormone optimization rather than self-managed or remotely prescribed therapy.
Is testosterone therapy for women FDA-approved?
No. There is currently no FDA-approved testosterone product indicated for use in women in the United States. This is a factual statement about the regulatory status of this therapy, not a commentary on whether it is appropriate or effective.
When a provider prescribes testosterone to a woman, that prescription is off-label. Off-label prescribing is legal throughout medicine and is the standard of care for many accepted treatments across multiple specialties. It is not inherently unsafe or experimental. It means the manufacturer did not pursue FDA approval for that specific indication, which is a commercial and regulatory decision, not solely a scientific one. Testosterone has been used off-label for postmenopausal women and documented in clinical literature for decades.
Off-label status does place more responsibility on the prescriber. Informed consent matters. The patient should understand the regulatory status of what she is receiving. Provider oversight, proper monitoring, and documentation are more important in an off-label context, not less. Any practice that obscures this or minimizes it is worth a second look.
Who is a candidate for testosterone therapy, and who is not?
Women who are typically evaluated as potential candidates include those in perimenopause or postmenopause with documented symptoms and lab findings consistent with testosterone deficiency, as well as premenopausal women with a clear clinical picture of deficiency after other causes have been ruled out.
Women who are pregnant, breastfeeding, or planning to become pregnant are not candidates. Testosterone is teratogenic and poses serious risk to fetal development. This is not a modifiable contraindication.
Testosterone therapy also requires additional caution, or may not be appropriate, for women with a history of hormone-sensitive breast or uterine cancer, active liver disease, uncontrolled cardiovascular disease, or unexplained vaginal bleeding. Each of these requires individualized clinical review.
Before testosterone is considered, other causes of the presenting symptoms should be evaluated and addressed. Thyroid dysfunction, iron deficiency, sleep disorders, depression, and medication side effects can each produce symptoms that closely resemble low testosterone. Starting testosterone therapy without ruling these out first is premature and can lead to attributing improvement, or lack of improvement, to the wrong cause.
Why in-person evaluation matters. Body Balance Medical provides individualized clinical counseling before any treatment decision. There are no mystery pellets, no remote scripts, and no six-month gaps without labs. If you are not a candidate right now, Mia will tell you, and tell you why.
How does Body Balance Medical approach testosterone therapy for women?
Mia LoPreiato, NP leads hormone optimization at Body Balance Medical's Summerlin clinic. Mia is Biote-Certified and evaluates women for testosterone therapy through an in-person process that begins with a full symptom review, health history, and targeted lab work. The evaluation is not built around a preset package. It is built around what your labs and your clinical picture actually show.
Your visit is a one-to-one consultation of roughly an hour at our Las Vegas clinic. Mia reviews symptoms, sexual health concerns, medications, prior hormone use, lifestyle, labs, and your goals. Potential benefits, risks, timeline, and side effects are explained before any treatment decision is made.
Monitoring. Follow-up typically includes total and free testosterone, a complete blood count to track hematocrit, a lipid profile, liver function testing, and estradiol and progesterone when clinically appropriate. Repeat labs are generally drawn within four to six weeks of starting therapy, then at approximately six-month intervals as a baseline cadence, and sooner if symptoms arise. Patients are told specifically what to watch for between visits.
For women whose evaluation points toward a broader hormonal picture, testosterone may be considered alongside other therapies. Our complete guide to bioidentical hormone replacement therapy covers how those pieces fit together.
Body Balance Medical is LegitScript certified, an independent third-party standard covering legal prescribing, advertising compliance, and medication handling. Services are available to patients in Nevada.
Frequently Asked Questions
Is testosterone therapy part of HRT for women?
Testosterone is sometimes included as part of a broader hormonal regimen that patients may refer to as HRT, typically alongside estrogen and progesterone in postmenopausal women. At Body Balance Medical the clinical approach is called hormone optimization rather than HRT, because the goal is to identify and address what is specifically deficient in each individual rather than applying a standardized replacement protocol. Whether testosterone is included depends entirely on lab results, symptom profile, and clinical evaluation. It is not automatically added to any program. Some women benefit from testosterone in combination with other hormones; others are evaluated for it in isolation.
Will testosterone therapy make me look or sound masculine?
Androgenic side effects including facial hair growth, voice deepening, and scalp hair thinning are possible with testosterone therapy in women. The likelihood and severity are strongly influenced by dose. At the concentrations typically used in female hormone optimization, significant virilization is uncommon when therapy is properly monitored. Voice changes warrant the most careful attention because they may not fully reverse. A provider who reviews your labs regularly and adjusts based on your response is not adding unnecessary steps; those checkpoints are what keep androgenic effects from becoming permanent. If you notice voice changes or rapid onset of other androgenic effects, contact your provider before your next scheduled visit.
How long before I notice a difference with testosterone therapy?
Response timelines vary by individual, delivery method, and the severity of the deficiency being addressed. Some patients report improvements in energy and libido within four to six weeks, particularly with pellet therapy. Other effects, including changes in body composition and cognitive clarity, tend to develop more gradually over several months. Full optimization, meaning the point at which labs and symptoms align at a stable, well-tolerated level, often takes multiple rounds of dosing and adjustment. Testosterone therapy should not be evaluated on how you feel in the first few weeks alone.
Do I still need estrogen or progesterone if I take testosterone?
Testosterone does not replace estrogen or progesterone in the female body. These hormones serve distinct functions, and a deficiency in one does not substitute for adequate levels of another. Whether estrogen or progesterone is also appropriate depends on menopausal status, symptom profile, and lab findings, and that assessment happens as part of a comprehensive hormonal evaluation. Some women prescribed testosterone are also found to have concurrent estrogen or progesterone deficiencies that warrant separate consideration; others are not. Women already taking estrogen or progesterone should make sure their provider has the full picture of their current regimen before any new therapy is added.
Are testosterone pellets better than injections or cream for women?
No delivery method is categorically superior for all women. Pellets offer infrequent dosing and relatively stable hormone levels, but cannot be adjusted once placed. Injections allow more flexible and responsive dose management, which is clinically useful when levels need to be dialed in or when response is variable. Topical creams are non-invasive and administered at home, but absorption is less consistent and the risk of inadvertent transfer to other household members requires careful adherence to application guidance. The method should be selected in conversation with your provider based on labs, lifestyle, and how important dose flexibility is for your situation.
Is testosterone therapy for women FDA approved?
No. There is no FDA-approved testosterone product indicated for women in the United States, so testosterone prescribed to women is off-label. Off-label prescribing is legal and widely practiced across medicine. What it requires is clear informed consent, provider oversight, and structured monitoring. The absence of an approved product does not mean the therapy is experimental, but it does mean the prescriber carries more responsibility for justifying the clinical decision.
Ready for a straight answer about your hormone picture?
Mia LoPreiato, NP sees women for in-depth hormone evaluations at our Summerlin clinic. Labs reviewed in context. Questions answered. A real clinical picture, not a remote script.
Schedule Your Hormone Evaluation (702) 417-1261 · 7975 W Sahara Ave #101, Las Vegas, NV 89117This article is for educational purposes only and does not constitute medical advice. Testosterone therapy for women is an off-label treatment in the United States. Individual results, candidacy, and side effect profiles vary and are not guaranteed. Consult a licensed healthcare provider before beginning or changing any hormone therapy. Body Balance Medical is a LegitScript-certified medical clinic in Summerlin, Las Vegas, NV.